Segment Information (Tables)

9 Months Ended

Sep. 30, 2019

Selected Financial Info by Reportable Segment

Selected financial information by reportable segment is presented below (in thousands):



	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Revenues, net:
Prescription Pharmaceuticals	$	155,568		$	148,469		$	461,962		$	484,933
Consumer Health	20,676			17,156			58,210			55,699
Total revenues, net	176,244			165,625			520,172			540,632

Gross Profit:
Prescription Pharmaceuticals	62,133			50,231			167,361			197,025
Consumer Health	9,269			7,031			25,538			23,744
Total gross profit	71,402			57,262			192,899			220,769

Operating expenses	62,634			133,242			336,980			413,330

OPERATING INCOME/(LOSS)	8,768			(75,980		)	(144,081		)	(192,561		)

Other expenses, net	(27,355		)	(12,559		)	(65,384		)	(36,261		)

(Loss) before income taxes	$	(18,587	)	$	(88,539	)	$	(209,465	)	$	(228,822	)

Revenue from External Customers by Geographic Areas

The following table sets forth the Company’s net revenues by geographic region for the three and nine month periods ended September 30, 2019 and 2018. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):



	Three Months Ended September 30, 2019			Three Months Ended September 30, 2018			Nine Months Ended September 30, 2019			Nine Months Ended September 30, 2018
Region	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues	Amount		% of Total Revenues
Domestic	$	171,986	97.6%	$	161,858	97.7%	$	510,228	98.1%	$	529,598	98.0%
Foreign	4,258		2.4%	3,767		2.3%	9,944		1.9%	11,034		2.0%
Total Revenues	$	176,244	100.0%	$	165,625	100.0%	$	520,172	100.0%	$	540,632	100.0%